Andrew Spokes portfolio, Q3 2025
Farallon Capital Management · 13F for the quarter ending Sep 30, 2025
For Q3 2025, Farallon Capital Management reported $17.7B across 139 US-listed positions, led by MSFT (5.6%), AON (4.6%) and EXEL (4.6%). Compared with its filing for Q2 2025, Andrew Spokes opened 21 new positions, added to 35, reduced 33 and sold out of 25; 50 positions did not change.
The largest purchase was a new position in ETHA ($234.8M); the largest sale, the sale of the whole position in SPY ($3.4B).
Key facts
- 13F portfolio value
- $17.7BQ3 2025
- Positions
- 139
- Largest holding
- MSFT 5.6%
- New positions
- 21
- Sold out
- 25
- Filed
- Nov 14, 2025
Holdings as of (Q3 2025), filed with the SEC on and amended on . Changes are measured against the filing for Jun 30, 2025. Every tracked investor's Q3 2025 13F.
Bought and sold in Q3 2025
| Stock | Move | Shares | Size | Of portfolio |
|---|---|---|---|---|
| SPDR S&P 500 ETFSPY | ▼ Sold out | −5.5M | $3.4B | 19.2% |
Hess Corpno ticker on file | ▼ Sold out | −5.81M | $804.2M | 4.54% |
| IQVIA Holdings IncIQV | ▼ Reduced 76% | −2.91M | $553.3M | 3.13% |
Liberty Broadband Corpno ticker on file | ▼ Sold out | −4.27M | $420.5M | 2.38% |
ANSYS Incno ticker on file | ▼ Sold out | −997.13K | $350.2M | 1.98% |
| iShares Ethereum Trust ETFETHA | ▲ New | +7.45M | $234.8M | 1.33% |
| Norfolk Southern CorpNSC | ▲ New | +615K | $184.8M | 1.04% |
| WabtecWAB | ▲ Added 69% | +896.9K | $179.8M | 1.02% |
Kellanovano ticker on file | ▲ Added 124% | +2.18M | $178.9M | 1.01% |
Verona Pharma Plcno ticker on file | ▼ Sold out | −1.81M | $171.2M | 0.97% |
Azek Co Incno ticker on file | ▼ Sold out | −3.14M | $170.7M | 0.96% |
| Lantheus Holdings IncLNTH | ▼ Reduced 48% | −3.25M | $166.4M | 0.94% |
| Alphabet IncGOOG | ▼ Reduced 36% | −640.9K | $156.1M | 0.88% |
| AramarkARMK | ▼ Reduced 30% | −3.9M | $149.9M | 0.85% |
| Hims & Hers Health IncHIMS | ▲ Added 31% | +2.53M | $143.7M | 0.81% |
| Exelixis IncEXEL | ▲ Added 22% | +3.47M | $143.1M | 0.81% |
Championx Corporationno ticker on file | ▼ Sold out | −4.25M | $105.4M | 0.60% |
| Aon PLCAON | ▲ Added 15% | +291.6K | $104M | 0.59% |
| Amazon.com IncAMZN | ▲ Added 16% | +471.1K | $103.4M | 0.58% |
| Teva Pharmaceutical IndustriesTEVA | ▲ New | +5M | $100.9M | 0.57% |
| Visa IncV | ▲ Added 94% | +291K | $99.3M | 0.56% |
| GE HealthCare Technologies IncGEHC | ▼ Reduced 100% | −1.32M | $99.1M | 0.56% |
| Liquidia CorporationLQDA | ▲ Added 102% | +4.33M | $98.4M | 0.56% |
| UnitedHealth Group IncUNH | ▲ Added 17% | +269.2K | $93M | 0.53% |
| Natera IncNTRA | ▼ Reduced 12% | −568.36K | $91.5M | 0.52% |
| Microsoft CorpMSFT | ▲ Added 9.5% | +165.3K | $85.6M | 0.48% |
| Salesforce IncCRM | ▲ Added 17% | +353.2K | $83.7M | 0.47% |
| CBRE Group IncCBRE | ▼ Reduced 24% | −497.1K | $78.3M | 0.44% |
| Boston Scientific CorpBSX | ▲ Added 19% | +765.5K | $74.7M | 0.42% |
| Woodward IncWWD | ▼ Reduced 32% | −292.7K | $74M | 0.42% |
| Abivax SAABVX | ▲ New | +805K | $68.3M | 0.39% |
| The Charles Schwab CorpSCHW | ▼ Reduced 18% | −707.4K | $67.5M | 0.38% |
| Mineralys Therapeutics IncMLYS | ▲ New | +1.67M | $63.4M | 0.36% |
| Thermo Fisher Scientific IncTMO | ▼ Reduced 9.0% | −125K | $60.6M | 0.34% |
Amedisys Incno ticker on file | ▼ Sold out | −575K | $56.6M | 0.32% |
| TransUnionTRU | ▼ Reduced 12% | −672.5K | $56.3M | 0.32% |
| Mara Holdings IncMARA | ▲ Added 338% | +2.83M | $51.6M | 0.29% |
| Grail IncGRAL | ▲ Added 169% | +847K | $50.1M | 0.28% |
| Grayscale Coindesk CryptoGDLC | ▲ New | +851.19K | $47.6M | 0.27% |
Crinetics Pharmaceuticalsno ticker on file | ▲ Added 24% | +1.12M | $46.8M | 0.26% |
| Nektar TherapeuticsNKTR | ▲ New | +791K | $45M | 0.25% |
JD.com Incno ticker on file | ▼ Sold out | — | $41.8M | 0.24% |
| Oscar Health IncOSCR | ▲ Added 147% | +2.16M | $40.9M | 0.23% |
| Nasdaq IncNDAQ | ▼ Reduced 11% | −460.7K | $40.7M | 0.23% |
Verve Therapeutics Incno ticker on file | ▼ Sold out | −3.61M | $40.6M | 0.23% |
| The Walt Disney CoDIS | ▲ Added 6.7% | +324.7K | $37.2M | 0.21% |
| New York Times Co MTN BeNYT | ▼ Reduced 11% | −623.8K | $35.8M | 0.20% |
| Mastercard IncMA | ▲ Added 41% | +61.7K | $35.1M | 0.20% |
| GeneDx Holdings CorpWGS | ▼ Reduced 98% | −321.68K | $34.7M | 0.20% |
| IntuitINTU | ▼ Reduced 9.1% | −48.57K | $33.2M | 0.19% |
| Uniqure NVQURE | ▲ Added more than 10× | +551K | $32.2M | 0.18% |
| Cardinal Health IncCAH | ▼ Reduced 44% | −201K | $31.5M | 0.18% |
| Assembly Biosciences IncASMB | ▲ New | +1.23M | $31.4M | 0.18% |
| New Oriental ED & TechnologyEDU | ▼ Reduced 51% | −590K | $31.3M | 0.18% |
| Healthequity IncHQY | ▼ Reduced 98% | −314.8K | $29.8M | 0.17% |
Cidara Therapeutics Incno ticker on file | ▲ Added 154% | +308K | $29.5M | 0.17% |
| Baidu IncBIDU | ▲ New | +208K | $27.4M | 0.15% |
| Doximity IncDOCS | ▲ New | +374K | $27.4M | 0.15% |
| Ultragenyx PharmaceuticalRARE | ▼ Reduced 99% | −891K | $26.8M | 0.15% |
| Autodesk IncADSK | ▼ Reduced 4.7% | −81.8K | $26M | 0.15% |
| Vnet Group IncVNET | ▲ Added 83% | +2.5M | $25.8M | 0.15% |
| Tenet Healthcare CorpTHC | ▼ Reduced 22% | −115K | $23.3M | 0.13% |
| Surgery Partners IncSGRY | ▼ Reduced 55% | −1.05M | $22.8M | 0.13% |
| Prime Medicine IncPRME | ▲ Added 533% | +4M | $22.2M | 0.13% |
MR Cooper Group Incno ticker on file | ▲ Added 81% | +99.5K | $21M | 0.12% |
| Alkermes PLCALKS | ▼ Reduced 97% | −670.86K | $20.1M | 0.11% |
| Abbott LabsABT | ▼ Sold out | −136K | $18.5M | 0.10% |
| Full Truck Alliance CoYMM | ▼ Sold out | −1.55M | $18.3M | 0.10% |
| Encompass Health CorpEHC | ▼ Reduced 19% | −137K | $17.4M | 0.10% |
Paramount Globalno ticker on file | ▼ Sold out | −1.35M | $17.4M | 0.10% |
| Schrodinger IncSDGR | ▼ Reduced 74% | −822K | $16.5M | 0.09% |
| Savara IncSVRA | ▼ Reduced 63% | −4.34M | $15.5M | 0.09% |
| Bridgebio Pharma IncBBIO | ▲ Added 3.7% | +292K | $15.2M | 0.09% |
| Revolution Medicines IncRVMD | ▲ Added 2.1% | +300K | $14M | 0.08% |
| Tango Therapeutics IncTNGX | ▲ Added 17% | +1.6M | $13.4M | 0.08% |
| Latam Airlines Group SALTM | ▼ Sold out | −318.09K | $12.9M | 0.07% |
Nuvalent Incno ticker on file | ▼ Reduced 98% | −147K | $12.7M | 0.07% |
| Globus Med IncGMED | ▼ Reduced 98% | −206K | $11.8M | 0.07% |
| Flutter Entertainment PLCFLUT | ▼ Reduced 24% | −43.86K | $11.1M | 0.06% |
| Intellia Therapeutics IncNTLA | ▲ New | +607.2K | $10.5M | 0.06% |
Soleno Therapeutics Incno ticker on file | ▲ Added more than 10× | +148K | $10M | 0.06% |
| Mckesson CorpMCK | ▲ Added 4.0% | +12.5K | $9.7M | 0.05% |
| JOYY IncJOYY | ▼ Reduced 21% | −162.91K | $9.5M | 0.05% |
| Analog Devices IncADI | ▲ Added 2.2% | +27.3K | $6.7M | 0.04% |
| Novavax IncNVAX | ▲ Added more than 10× | +764K | $6.6M | 0.04% |
| Helix Acquisition Corp IIHLXC | ▼ Sold out | −600K | $6.4M | 0.04% |
Liberty Broadband Corpno ticker on file | ▼ Sold out | −58.22K | $5.7M | 0.03% |
| Waystar Holding CorpWAY | ▲ Added 22% | +137K | $5.2M | 0.03% |
iShares Trustno ticker on file | ▲ New | +18.91K | $5.1M | 0.03% |
Allete Incno ticker on file | ▲ New | +75K | $5M | 0.03% |
Centessa Pharmaceuticals PLCno ticker on file | ▼ Reduced 4.4% | −198K | $4.8M | 0.03% |
| Tectonic Therapeutic IncTECX | ▼ Reduced 25% | −213.05K | $3.3M | 0.02% |
| Voyager Therapeutics IncVYGR | ▼ Sold out | −715K | $2.2M | 0.01% |
| Beta Bionics IncBBNX | ▲ Added 2.6% | +110K | $2.2M | 0.01% |
| iShares Bitcoin Trust ETFIBIT | ▼ Reduced 0.4% | −27.35K | $1.8M | 0.01% |
| Protagonist Therapeutics IncPTGX | ▲ Added 0.4% | +24K | $1.6M | 0.01% |
| Beam Therapeutics IncBEAM | ▲ Added 0.5% | +50K | $1.2M | 0.01% |
| Janux Therapeutics IncJANX | ▼ Sold out | −48K | $1.1M | 0.01% |
| Agios Pharmaceuticals IncAGIO | ▲ Added 0.2% | +13.6K | $545.9K | 0.00% |
Sage Therapeutics Incno ticker on file | ▼ Sold out | −42.8K | $390.3K | 0.00% |
| Ionis Pharmaceuticals IncIONS | ▲ New | +4.8K | $314K | 0.00% |
| United Therapeutics CorpUTHR | ▼ Sold out | −1K | $287.4K | 0.00% |
Merus N Vno ticker on file | ▲ New | +3K | $282.5K | 0.00% |
| Veracyte IncVCYT | ▲ New | +7K | $240.3K | 0.00% |
Springworks Therapeutics Incno ticker on file | ▼ Sold out | −5K | $235K | 0.00% |
| Mirum Pharmaceuticals IncMIRM | ▲ New | +3K | $219.9K | 0.00% |
| UroGen Pharma LtdURGN | ▲ New | +11K | $219.5K | 0.00% |
Akero Therapeutics Incno ticker on file | ▼ Sold out | −4K | $213.4K | 0.00% |
| Icon Pub Ltd CoICLR | ▲ New | +1.2K | $210K | 0.00% |
| Bruker CorpBRKR | ▼ Sold out | −5K | $206K | 0.00% |
| BioCryst Pharmaceuticals IncBCRX | ▲ New | +24K | $182.2K | 0.00% |
Blue Gold Ltdno ticker on file | ▲ New | +300K | $137.3K | 0.00% |
Third Harmonic Bio Incno ticker on file | ▼ Sold out | −15.36K | $83.4K | 0.00% |
| Biodesix IncBDSX | ▼ Sold out | −128K | $36.1K | 0.00% |
Holdings at the quarter's end
| # | Stock | Sector | Share of portfolio | Value | Shares | Reported price | Held | Since Q2 2025 |
|---|---|---|---|---|---|---|---|---|
| 1 | Microsoft CorpMSFT | Technology | 5.60% | $990.9M | 1.91M | $517.95 | 5+ qtrs | ▲ Added 9.5% |
| 2 | Aon PLCAON · SHS CL A | Financials | 4.59% | $812.3M | 2.28M | $356.58 | 5+ qtrs | ▲ Added 15% |
| 3 | Exelixis IncEXEL | Health Care | 4.55% | $805.4M | 19.5M | $41.30 | 5+ qtrs | ▲ Added 22% |
| 4 | Amazon.com IncAMZN | Consumer Discretionary | 4.35% | $769.7M | 3.51M | $219.57 | 2 qtrs | ▲ Added 16% |
| 5 | Natera IncNTRA | Health Care | 3.87% | $684.7M | 4.25M | $160.97 | 5+ qtrs | ▼ Reduced 12% |
| 6 | Revolution Medicines IncRVMD | Health Care | 3.86% | $683M | 14.63M | $46.70 | 5+ qtrs | ▲ Added 2.1% |
| 7 | UnitedHealth Group IncUNH | Health Care | 3.68% | $651.4M | 1.89M | $345.30 | 5+ qtrs | ▲ Added 17% |
| 8 | Thermo Fisher Scientific IncTMO | Health Care | 3.45% | $610.3M | 1.26M | $485.02 | 5+ qtrs | ▼ Reduced 9.0% |
| 9 | Hims & Hers Health IncHIMS | Health Care | 3.44% | $609.6M | 10.75M | $56.72 | 5+ qtrs | ▲ Added 31% |
| 10 | The Walt Disney CoDIS | Communication | 3.36% | $595.3M | 5.2M | $114.50 | 5+ qtrs | ▲ Added 6.7% |
| 11 | Salesforce IncCRM | Technology | 3.30% | $583.6M | 2.46M | $237.00 | 5+ qtrs | ▲ Added 17% |
| 12 | Autodesk IncADSK | Technology | 2.99% | $528.2M | 1.66M | $317.67 | 4 qtrs | ▼ Reduced 4.7% |
| 13 | Boston Scientific CorpBSX | Health Care | 2.62% | $463.4M | 4.75M | $97.63 | 5+ qtrs | ▲ Added 19% |
| 14 | iShares Bitcoin Trust ETFIBIT · SHS BEN INT | — | 2.57% | $454.5M | 6.99M | $65.00 | 5+ qtrs | ▼ Reduced 0.4% |
| 15 | WabtecWAB | Industrials | 2.50% | $442.1M | 2.21M | $200.47 | 5+ qtrs | ▲ Added 69% |
| 16 | Bridgebio Pharma IncBBIO | Health Care | 2.40% | $425.5M | 8.19M | $51.94 | 5+ qtrs | ▲ Added 3.7% |
| 17 | Protagonist Therapeutics IncPTGX | Health Care | 2.33% | $411.6M | 6.2M | $66.43 | 5+ qtrs | ▲ Added 0.4% |
| 18 | TransUnionTRU | Industrials | 2.24% | $396.5M | 4.73M | $83.78 | 5+ qtrs | ▼ Reduced 12% |
| 19 | AramarkARMK | Consumer Discretionary | 1.95% | $345.5M | 9M | $38.40 | 5+ qtrs | ▼ Reduced 30% |
| 20 | IntuitINTU | Technology | 1.88% | $333.3M | 488.09K | $682.91 | 5+ qtrs | ▼ Reduced 9.1% |
| 21 | Kellanovano ticker on file | — | 1.83% | $323.5M | 3.94M | $82.02 | 4 qtrs | ▲ Added 124% |
| 22 | Nasdaq IncNDAQ | Financials | 1.81% | $320.5M | 3.62M | $88.45 | 5+ qtrs | ▼ Reduced 11% |
| 23 | Analog Devices IncADI | Technology | 1.80% | $319.3M | 1.3M | $245.70 | 5+ qtrs | ▲ Added 2.2% |
| 24 | The Charles Schwab CorpSCHW | Financials | 1.75% | $310.4M | 3.25M | $95.47 | 4 qtrs | ▼ Reduced 18% |
| 25 | New York Times Co MTN BeNYT · CL A | Communication | 1.62% | $286.2M | 4.99M | $57.40 | 5+ qtrs | ▼ Reduced 11% |
| 26 | Alphabet IncGOOG · CAP STK CL C | — | 1.54% | $273M | 1.12M | $243.55 | 5+ qtrs | ▼ Reduced 36% |
| 27 | CBRE Group IncCBRE · CL A | Real Estate | 1.44% | $254.6M | 1.62M | $157.56 | 5+ qtrs | ▼ Reduced 24% |
| 28 | Mckesson CorpMCK | Health Care | 1.43% | $252.7M | 327.1K | $772.54 | 4 qtrs | ▲ Added 4.0% |
| 29 | Beam Therapeutics IncBEAM | — | 1.38% | $244.2M | 10.06M | $24.27 | 5+ qtrs | ▲ Added 0.5% |
| 30 | Crinetics Pharmaceuticalsno ticker on file | — | 1.36% | $240.3M | 5.77M | $41.65 | 5+ qtrs | ▲ Added 24% |
| 31 | iShares Ethereum Trust ETFETHA · SHS | — | 1.33% | $234.8M | 7.45M | $31.51 | 1 qtr | New |
| 32 | Agios Pharmaceuticals IncAGIO | — | 1.31% | $232.1M | 5.78M | $40.14 | 5+ qtrs | ▲ Added 0.2% |
| 33 | Visa IncV | Financials | 1.16% | $204.8M | 599.81K | $341.38 | 5+ qtrs | ▲ Added 94% |
| 34 | Liquidia CorporationLQDA | — | 1.10% | $194.8M | 8.57M | $22.74 | 5+ qtrs | ▲ Added 102% |
| 35 | Norfolk Southern CorpNSC | Industrials | 1.04% | $184.8M | 615K | $300.41 | 1 qtr | New |
| 36 | Lantheus Holdings IncLNTH | Health Care | 1.01% | $178.3M | 3.48M | $51.29 | 5+ qtrs | ▼ Reduced 48% |
| 37 | IQVIA Holdings IncIQV | Health Care | 1.01% | $178.3M | 938.55K | $189.94 | 5+ qtrs | ▼ Reduced 76% |
| 38 | Woodward IncWWD | Industrials | 0.89% | $157.2M | 621.97K | $252.71 | 5+ qtrs | ▼ Reduced 32% |
| 39 | Mastercard IncMA · CL A | Financials | 0.69% | $121.6M | 213.77K | $568.81 | 5+ qtrs | ▲ Added 41% |
| 40 | Centessa Pharmaceuticals PLCno ticker on file · SPONSORED ADS | — | 0.59% | $105M | 4.33M | $24.25 | 5+ qtrs | ▼ Reduced 4.4% |
| 41 | Teva Pharmaceutical IndustriesTEVA · SPONSORED ADS | Health Care | 0.57% | $100.9M | 5M | $20.20 | 1 qtr | New |
| 42 | Tango Therapeutics IncTNGX | — | 0.51% | $90.4M | 10.76M | $8.40 | 4 qtrs | ▲ Added 17% |
| 43 | Beta Bionics IncBBNX | — | 0.48% | $85.7M | 4.31M | $19.87 | 3 qtrs | ▲ Added 2.6% |
| 44 | Tenet Healthcare CorpTHC | Health Care | 0.48% | $84.1M | 414K | $203.04 | 2 qtrs | ▼ Reduced 22% |
| 45 | Grail IncGRAL | Health Care | 0.45% | $79.8M | 1.35M | $59.13 | 2 qtrs | ▲ Added 169% |
| 46 | Encompass Health CorpEHC | Health Care | 0.41% | $72.5M | 571K | $127.02 | 5+ qtrs | ▼ Reduced 19% |
| 47 | Oscar Health IncOSCR · CL A | Health Care | 0.39% | $68.9M | 3.64M | $18.93 | 5+ qtrs | ▲ Added 147% |
| 48 | Abivax SAABVX · SPONSORED ADS | Health Care | 0.39% | $68.3M | 805K | $84.90 | 1 qtr | New |
| 49 | Mara Holdings IncMARA | — | 0.38% | $66.8M | 3.66M | $18.26 | 4 qtrs | ▲ Added 338% |
| 50 | Mineralys Therapeutics IncMLYS | — | 0.36% | $63.4M | 1.67M | $37.92 | 1 qtr | New |
| 51 | Vnet Group IncVNET · SPONSORED ADS A | — | 0.32% | $56.7M | 5.49M | $10.33 | 5+ qtrs | ▲ Added 83% |
| 52 | Cidara Therapeutics Incno ticker on file | — | 0.28% | $48.6M | 508K | $95.76 | 2 qtrs | ▲ Added 154% |
| 53 | Grayscale Coindesk CryptoGDLC · USD SHS | — | 0.27% | $47.6M | 851.19K | $55.90 | 1 qtr | New |
| 54 | MR Cooper Group Incno ticker on file | — | 0.26% | $46.8M | 222K | $210.79 | 2 qtrs | ▲ Added 81% |
| 55 | Nektar TherapeuticsNKTR | — | 0.25% | $45M | 791K | $56.90 | 1 qtr | New |
| 56 | Cardinal Health IncCAH | Health Care | 0.22% | $39.7M | 253K | $156.96 | 3 qtrs | ▼ Reduced 44% |
| 57 | JOYY IncJOYY · ADS REPSTG COM A | — | 0.21% | $36.6M | 625K | $58.61 | 3 qtrs | ▼ Reduced 21% |
| 58 | Flutter Entertainment PLCFLUT · SHS | Technology | 0.20% | $34.9M | 137.37K | $254.00 | 5+ qtrs | ▼ Reduced 24% |
| 59 | Uniqure NVQURE · SHS | — | 0.19% | $33M | 565K | $58.37 | 3 qtrs | ▲ Added more than 10× |
| 60 | Assembly Biosciences IncASMB | — | 0.18% | $31.4M | 1.23M | $25.60 | 1 qtr | New |
| 61 | New Oriental ED & TechnologyEDU · SPON ADR | Consumer Discretionary | 0.17% | $30M | 565.15K | $53.07 | 5+ qtrs | ▼ Reduced 51% |
| 62 | Waystar Holding CorpWAY | Technology | 0.16% | $28.4M | 750K | $37.92 | 4 qtrs | ▲ Added 22% |
| 63 | Baidu IncBIDU · SPON ADR REP A | Technology | 0.16% | $27.4M | 208K | $131.77 | 1 qtr | New |
| 64 | Doximity IncDOCS · CL A | Technology | 0.16% | $27.4M | 374K | $73.15 | 1 qtr | New |
| 65 | Prime Medicine IncPRME | — | 0.15% | $26.3M | 4.75M | $5.54 | 5+ qtrs | ▲ Added 533% |
| 66 | Enanta Pharmaceuticals IncENTA | — | 0.14% | $25.4M | 2.12M | $11.97 | 5+ qtrs | No change |
| 67 | Surgery Partners IncSGRY | — | 0.11% | $18.9M | 871.83K | $21.64 | 2 qtrs | ▼ Reduced 55% |
| 68 | Tyra Biosciences IncTYRA | — | 0.09% | $16M | 1.14M | $13.99 | 4 qtrs | No change |
| 69 | Intellia Therapeutics IncNTLA | — | 0.06% | $10.5M | 607.2K | $17.27 | 1 qtr | New |
| 70 | Soleno Therapeutics Incno ticker on file | — | 0.06% | $10.3M | 153K | $67.60 | 4 qtrs | ▲ Added more than 10× |
| 71 | Tectonic Therapeutic IncTECX | — | 0.06% | $10M | 640K | $15.69 | 5+ qtrs | ▼ Reduced 25% |
| 72 | Savara IncSVRA | — | 0.05% | $8.9M | 2.5M | $3.57 | 5+ qtrs | ▼ Reduced 63% |
| 73 | Novavax IncNVAX | — | 0.04% | $6.8M | 780K | $8.67 | 5+ qtrs | ▲ Added more than 10× |
| 74 | Schrodinger IncSDGR | — | 0.03% | $5.7M | 284K | $20.06 | 2 qtrs | ▼ Reduced 74% |
| 75 | iShares Trustno ticker on file · ISHARES SEMICDTR | — | 0.03% | $5.1M | 18.91K | $271.12 | 1 qtr | New |
| 76 | Allete Incno ticker on file | — | 0.03% | $5M | 75K | $66.40 | 1 qtr | New |
| 77 | Tvardi Therapeutics IncTVRD | — | 0.01% | $1.7M | 43.23K | $38.97 | 2 qtrs | No change |
| 78 | Alvotech SAALVO · ORDINARY SHARES | — | 0.01% | $1.6M | 199.68K | $8.19 | 5+ qtrs | No change |
| 79 | Madrigal Pharmaceuticals IncMDGL | Health Care | 0.01% | $1.5M | 3.32K | $458.66 | 5+ qtrs | No change |
| 80 | Summit Midstream CorporationSMC | — | 0.01% | $1.2M | 58.21K | $20.54 | 5+ qtrs | No change |
| 81 | Brightspring Health Services IncBTSG | Health Care | 0.00% | $650.3K | 22K | $29.56 | 5+ qtrs | No change |
| 82 | Alkermes PLCALKS · SHS | Health Care | 0.00% | $624K | 20.8K | $30.00 | 3 qtrs | ▼ Reduced 97% |
| 83 | Roivant Sciences LtdROIV · SHS | Health Care | 0.00% | $559.8K | 37K | $15.13 | 5+ qtrs | No change |
| 84 | Arrowhead PharmaceuticalsARWR | Health Care | 0.00% | $544.9K | 15.8K | $34.49 | 4 qtrs | No change |
| 85 | GeneDx Holdings CorpWGS | — | 0.00% | $538.7K | 5K | $107.74 | 4 qtrs | ▼ Reduced 98% |
| 86 | Guardant Health IncGH | Health Care | 0.00% | $499.8K | 8K | $62.48 | 2 qtrs | No change |
| 87 | Arcutis Biotherapeutics IncARQT | — | 0.00% | $490.1K | 26K | $18.85 | 5+ qtrs | No change |
| 88 | Axsome Therapeutics IncAXSM | Health Care | 0.00% | $485.8K | 4K | $121.45 | 5+ qtrs | No change |
| 89 | Healthequity IncHQY | Health Care | 0.00% | $473.9K | 5K | $94.77 | 5+ qtrs | ▼ Reduced 98% |
| 90 | Insmed IncINSM | Health Care | 0.00% | $432K | 3K | $144.01 | 5+ qtrs | No change |
| 91 | Progyny IncPGNY | — | 0.00% | $387.4K | 18K | $21.52 | 5+ qtrs | No change |
| 92 | Beone Medicines LtdONC · SPONSORED ADS | Health Care | 0.00% | $374.8K | 1.1K | $340.70 | 5+ qtrs | No change |
| 93 | Krystal Biotech IncKRYS | Health Care | 0.00% | $353.1K | 2K | $176.53 | 5+ qtrs | No change |
| 94 | Arcellx Incno ticker on file | — | 0.00% | $328.4K | 4K | $82.10 | 5+ qtrs | No change |
| 95 | CG Oncology IncCGON | Health Care | 0.00% | $322.2K | 8K | $40.28 | 2 qtrs | No change |
| 96 | Livanova PLCLIVN · SHS | Health Care | 0.00% | $314.3K | 6K | $52.38 | 3 qtrs | No change |
| 97 | Ionis Pharmaceuticals IncIONS | Health Care | 0.00% | $314K | 4.8K | $65.42 | 1 qtr | New |
| 98 | Cencora IncCOR | Health Care | 0.00% | $312.5K | 1K | $312.53 | 5+ qtrs | No change |
| 99 | Capricor Therapeutics IncCAPR | — | 0.00% | $295.6K | 41K | $7.21 | 4 qtrs | No change |
| 100 | Travere Therapeutics IncTVTX | Health Care | 0.00% | $286.8K | 12K | $23.90 | 2 qtrs | No change |
| 101 | Merus N Vno ticker on file | — | 0.00% | $282.5K | 3K | $94.15 | 1 qtr | New |
| 102 | Grifols S AGRFS · SP ADR REP B NVT | Health Care | 0.00% | $278.9K | 28K | $9.96 | 5+ qtrs | No change |
| 103 | Ascendis Pharma A/SASND · SPONSORED ADR | Health Care | 0.00% | $278.3K | 1.4K | $198.81 | 3 qtrs | No change |
| 104 | Sabra Health Care REIT IncSBRA | Real Estate | 0.00% | $261K | 14K | $18.64 | 5+ qtrs | No change |
| 105 | Scholar Rock Holding CorpSRRK | Health Care | 0.00% | $260.7K | 7K | $37.24 | 4 qtrs | No change |
| 106 | Nuvalent Incno ticker on file | — | 0.00% | $259.4K | 3K | $86.48 | 5+ qtrs | ▼ Reduced 98% |
| 107 | Merit Med Systems IncMMSI | Health Care | 0.00% | $249.7K | 3K | $83.23 | 5+ qtrs | No change |
| 108 | Cogent Biosciences IncCOGT | Health Care | 0.00% | $244.1K | 17K | $14.36 | 5+ qtrs | No change |
| 109 | Veracyte IncVCYT | — | 0.00% | $240.3K | 7K | $34.33 | 1 qtr | New |
| 110 | Globus Med IncGMED · CL A | Health Care | 0.00% | $229.1K | 4K | $57.27 | 5+ qtrs | ▼ Reduced 98% |
| 111 | Aleanna Incno ticker on file · *W EXP 12/13/202 | — | 0.00% | $225.7K | 990K | $0.2280 | 4 qtrs | No change |
| 112 | GE HealthCare Technologies IncGEHC | Health Care | 0.00% | $225.3K | 3K | $75.10 | 4 qtrs | ▼ Reduced 100% |
| 113 | Mirum Pharmaceuticals IncMIRM | Health Care | 0.00% | $219.9K | 3K | $73.31 | 1 qtr | New |
| 114 | UroGen Pharma LtdURGN | — | 0.00% | $219.5K | 11K | $19.95 | 1 qtr | New |
| 115 | Healthcare Realty TrustHR · CL A COM | Real Estate | 0.00% | $216.4K | 12K | $18.03 | 5+ qtrs | No change |
| 116 | Twist Bioscience CorpTWST | Health Care | 0.00% | $215.3K | 7.65K | $28.14 | 5+ qtrs | No change |
| 117 | Glaukos CorpGKOS | Health Care | 0.00% | $212K | 2.6K | $81.55 | 5+ qtrs | No change |
| 118 | Ultragenyx PharmaceuticalRARE | — | 0.00% | $210.6K | 7K | $30.08 | 2 qtrs | ▼ Reduced 99% |
| 119 | Icon Pub Ltd CoICLR · SHS | Health Care | 0.00% | $210K | 1.2K | $175.00 | 1 qtr | New |
| 120 | Immunovant IncIMVT | Health Care | 0.00% | $193.4K | 12K | $16.12 | 5+ qtrs | No change |
| 121 | BioCryst Pharmaceuticals IncBCRX | — | 0.00% | $182.2K | 24K | $7.59 | 1 qtr | New |
| 122 | Pacific Biosciences of California IncPACB | — | 0.00% | $172.8K | 135K | $1.28 | 5+ qtrs | No change |
| 123 | Solid Power Incno ticker on file · *W EXP 12/08/202 | — | 0.00% | $168.4K | 405.32K | $0.4155 | 5+ qtrs | No change |
| 124 | Syndax Pharmaceuticals IncSNDX | — | 0.00% | $153.9K | 10K | $15.39 | 5+ qtrs | No change |
| 125 | Blue Gold Ltdno ticker on file · *W EXP 04/01/203 | — | 0.00% | $137.3K | 300K | $0.4576 | 1 qtr | New |
| 126 | Ardelyx IncARDX | — | 0.00% | $126.7K | 23K | $5.51 | 5+ qtrs | No change |
| 127 | Dyne Therapeutics IncDYN | — | 0.00% | $126.5K | 10K | $12.65 | 5+ qtrs | No change |
| 128 | Amicus Therapeuticno ticker on file | — | 0.00% | $126.1K | 16K | $7.88 | 5+ qtrs | No change |
| 129 | Evolent Health IncEVH · CL A | — | 0.00% | $118.4K | 14K | $8.46 | 5+ qtrs | No change |
| 130 | Altimmune IncALT | — | 0.00% | $104.1K | 27.6K | $3.77 | 5+ qtrs | No change |
| 131 | C4 Therapeutics IncCCCC | — | 0.00% | $62.2K | 28K | $2.22 | 5+ qtrs | No change |
| 132 | Aleanna Incno ticker on file | — | 0.00% | $61.8K | 78.4K | $0.7885 | 4 qtrs | No change |
| 133 | Geron CorpGERN | — | 0.00% | $58.9K | 43K | $1.37 | 5+ qtrs | No change |
| 134 | Iovance Biotherapeutics IncIOVA | — | 0.00% | $56.4K | 26K | $2.17 | 5+ qtrs | No change |
| 135 | Canopy Growth CorporationCGC | — | 0.00% | $43.8K | 30K | $1.46 | 5+ qtrs | No change |
| 136 | Revolution Medicines Incno ticker on file · *W EXP 12/17/202 | — | 0.00% | $36K | 120.09K | $0.3000 | 5+ qtrs | No change |
| 137 | Beyond Meat IncBYND | — | 0.00% | $35.9K | 19K | $1.89 | 5+ qtrs | No change |
| 138 | Nvni Group Limitedno ticker on file · *W EXP 11/01/202 | — | 0.00% | $27K | 375K | $0.0720 | 5+ qtrs | No change |
| 139 | Ironwood Pharmaceuticals IncIRWD | — | 0.00% | $17K | 13K | $1.31 | 5+ qtrs | No change |
By sector
| Sector | Share of portfolio | Value | Positions |
|---|---|---|---|
| Health Care | 36.6% | $6.5B | 47 |
| Technology | 16.2% | $2.9B | 9 |
| Financials | 10.00% | $1.8B | 5 |
| Industrials | 6.67% | $1.2B | 4 |
| Consumer Discretionary | 6.47% | $1.1B | 3 |
| Communication | 4.98% | $881.5M | 2 |
| Real Estate | 1.44% | $255.1M | 3 |
| No sector on file | 17.6% | $3.1B | 66 |
Questions and answers
What did Andrew Spokes own in Q3 2025?
Farallon Capital Management's 13F for Q3 2025 lists 139 positions worth $17.7B. The largest: MSFT (5.6%), AON (4.6%), EXEL (4.6%), AMZN (4.3%), NTRA (3.9%).
What did Andrew Spokes buy in Q3 2025?
The largest purchases, by the shares bought at the quarter-end price the filing implies: ETHA (new, $234.8M), NSC (new, $184.8M), WAB (added, $179.8M), Kellanova (added, $178.9M), HIMS (added, $143.7M), EXEL (added, $143.1M).
What did Andrew Spokes sell in Q3 2025?
The largest sales: SPY (sold out, $3.4B), Hess Corp (sold out, $804.2M), IQV (reduced, $553.3M), Liberty Broadband Corp (sold out, $420.5M), ANSYS Inc (sold out, $350.2M), Verona Pharma Plc (sold out, $171.2M).
When was this filing made?
Farallon Capital Management filed its 13F for the quarter ending Sep 30, 2025 on Nov 14, 2025, and amended it on Feb 17, 2026; the figures here include the amendment. A 13F is due within 45 days of the quarter's end, so the positions were already weeks old when it became public.
Learn
Cite this page
Funkfolio, “Andrew Spokes portfolio, Q3 2025: Farallon Capital Management 13F holdings”, data as of 17 February 2026. https://funkfolio.com/gurus/farallon/2025-q3
Underlying data: SEC EDGAR, Form 13F-HR of Farallon Capital Management (CIK 909661) for the period ending Sep 30, 2025.
Source: SEC EDGAR, Form 13F-HR for Farallon Capital Management (CIK 909661), period ending Sep 30, 2025, filed Nov 14, 2025, amended Feb 17, 2026. Changes compare share counts with the filing for Jun 30, 2025; a share split in between is allowed for where one is on record. “Reported price” is a position's reported value divided by its shares. The size of a buy or sell is the change in shares at that price; a position sold out is sized at its value in the previous filing, and “of portfolio” sets the size against the $17.7B reported for this quarter. “Held” counts consecutive quarterly filings up to this one, out of the 5 looked at from here back. Sectors are those of the ranked companies on this site as they stand today. 5 option positions in the filing are not shown. Not a live portfolio and not advice.